APA (7th ed.) Citation

Smith, R. H., Bloomer, H., Fink, D., Keyvanfar, K., Nasimuzzaman, M., Sancheznieto, F., . . . Larochelle, A. (2022). Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1. Human Gene Therapy, 33(23/24), 1293. https://doi.org/10.1089/hum.2022.065

Chicago Style (17th ed.) Citation

Smith, Richard H., et al. "Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1." Human Gene Therapy 33, no. 23/24 (2022): 1293. https://doi.org/10.1089/hum.2022.065.

MLA (9th ed.) Citation

Smith, Richard H., et al. "Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1." Human Gene Therapy, vol. 33, no. 23/24, 2022, p. 1293, https://doi.org/10.1089/hum.2022.065.